Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)
CNY 8.73
(-0.8%)
CNY 8.73
(-0.8%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 677.37 Million CNY | -10.47% |
| 2022 | 756.55 Million CNY | 24.82% |
| 2021 | 606.11 Million CNY | 39.26% |
| 2020 | 435.22 Million CNY | -4.64% |
| 2019 | 456.41 Million CNY | -10.21% |
| 2018 | 508.31 Million CNY | -11.59% |
| 2017 | 574.95 Million CNY | 612.2% |
| 2016 | 80.72 Million CNY | 65.69% |
| 2015 | 48.72 Million CNY | -25.8% |
| 2014 | 65.66 Million CNY | -16.29% |
| 2013 | 78.44 Million CNY | -36.74% |
| 2012 | 123.99 Million CNY | -29.52% |
| 2011 | 175.93 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 591.78 Million CNY | -12.64% |
| 2024 Q3 | 397.86 Million CNY | 1.62% |
| 2024 Q2 | 391.52 Million CNY | -33.84% |
| 2023 Q3 | 611.86 Million CNY | -3.58% |
| 2023 Q2 | 634.6 Million CNY | 6.72% |
| 2023 FY | 677.37 Million CNY | -10.47% |
| 2023 Q4 | 677.37 Million CNY | 10.71% |
| 2023 Q1 | 594.64 Million CNY | -21.4% |
| 2022 Q4 | 756.55 Million CNY | 59.4% |
| 2022 FY | 756.55 Million CNY | 24.82% |
| 2022 Q3 | 474.63 Million CNY | 10.06% |
| 2022 Q2 | 431.23 Million CNY | -5.23% |
| 2022 Q1 | 455.04 Million CNY | -24.93% |
| 2021 FY | 606.11 Million CNY | 39.26% |
| 2021 Q4 | 606.11 Million CNY | 41.74% |
| 2021 Q3 | 427.64 Million CNY | 2.76% |
| 2021 Q2 | 416.17 Million CNY | -10.39% |
| 2021 Q1 | 464.44 Million CNY | 6.71% |
| 2020 Q2 | 365.06 Million CNY | -5.11% |
| 2020 Q4 | 435.22 Million CNY | 15.83% |
| 2020 Q1 | 384.72 Million CNY | -15.71% |
| 2020 FY | 435.22 Million CNY | -4.64% |
| 2020 Q3 | 375.75 Million CNY | 2.93% |
| 2019 Q3 | 365.35 Million CNY | 9.54% |
| 2019 Q4 | 456.41 Million CNY | 24.92% |
| 2019 Q2 | 333.54 Million CNY | -18.42% |
| 2019 FY | 456.41 Million CNY | -10.21% |
| 2019 Q1 | 408.85 Million CNY | -19.57% |
| 2018 Q2 | 407.17 Million CNY | -14.64% |
| 2018 FY | 508.31 Million CNY | -11.59% |
| 2018 Q4 | 508.31 Million CNY | 31.8% |
| 2018 Q3 | 385.66 Million CNY | -5.28% |
| 2018 Q1 | 477.03 Million CNY | -17.03% |
| 2017 Q3 | 373.96 Million CNY | -70.24% |
| 2017 FY | 574.95 Million CNY | 612.2% |
| 2017 Q1 | 84.88 Million CNY | 5.14% |
| 2017 Q2 | 1.25 Billion CNY | 1380.4% |
| 2017 Q4 | 574.95 Million CNY | 53.74% |
| 2016 Q4 | 80.72 Million CNY | -4.29% |
| 2016 Q3 | 84.34 Million CNY | 39.13% |
| 2016 Q2 | 60.62 Million CNY | 16.11% |
| 2016 Q1 | 52.21 Million CNY | 7.16% |
| 2016 FY | 80.72 Million CNY | 65.69% |
| 2015 Q1 | 53.08 Million CNY | -19.16% |
| 2015 Q4 | 48.72 Million CNY | 22.57% |
| 2015 FY | 48.72 Million CNY | -25.8% |
| 2015 Q3 | 39.75 Million CNY | -22.73% |
| 2015 Q2 | 51.44 Million CNY | -3.09% |
| 2014 FY | 65.66 Million CNY | -16.29% |
| 2014 Q1 | 87.6 Million CNY | 0.0% |
| 2014 Q4 | 65.66 Million CNY | 0.0% |
| 2013 FY | 78.44 Million CNY | -36.74% |
| 2012 FY | 123.99 Million CNY | -29.52% |
| 2011 FY | 175.93 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| China National Complete Plant Import & Export Corporation Limited | 2.45 Billion CNY | 72.36% |